Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.

@article{Thorp2012TreatmentOH,
  title={Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.},
  author={John M Thorp and James Simon and Dan Dattani and Leslie C. Taylor and Toshio Kimura and Miguel García and Lynna M. Lesko and Robert E. Pyke},
  journal={The journal of sexual medicine},
  year={2012},
  volume={9 3},
  pages={
          793-804
        }
}
INTRODUCTION Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or interpersonal difficulty. AIM To assess the efficacy and tolerability of flibanserin, a postsynaptic 5-HT1A agonist/5-HT2A antagonist, in the treatment of premenopausal women with HSDD. METHODS North American premenopausal women with HSDD (mean age 35 years) were randomized to 24 weeks' treatment with flibanserin 25 mg twice daily (N=396), 50 mg twice daily (N=392), 100… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 58 CITATIONS, ESTIMATED 40% COVERAGE

Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women

Catherine A. Millares-Sipin, Ximena Vallejos, Christine Wu
  • 2017
VIEW 7 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Modeling Human Sexual Motivation in Rodents: Some Caveats

Olivia Le Moëne, Anders Ågmo
  • Front. Behav. Neurosci.
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 7 Citations per year from 2017 through 2019